State of Wisconsin Investment Board
IGMS

State of Wisconsin Investment Board’s IGM Biosciences IGMS Stock Holding History

State of Wisconsin Investment Board’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-29,600
Closed -$246K – 2319
2023
Q4 		$246K Buy
29,600
+17,872
+152% +$104K ﹤0.01% 2134
2023
Q3 		$97.9K Buy
+11,728
New +$99.5K ﹤0.01% 2368
2022
Q4 		– Sell
-9,388
Closed -$213K – 2577
2022
Q3 		$213K Buy
+9,388
New +$190K ﹤0.01% 2379
2022
Q2 		– Sell
-43,800
Closed -$1.17M – 2843
2022
Q1 		$1.17M Buy
43,800
+33,700
+334% +$627K ﹤0.01% 1608
2021
Q4 		$296K Hold
10,100
– – ﹤0.01% 1969
2021
Q3 		$664K Hold
10,100
– – ﹤0.01% 1590
2021
Q2 		$840K Sell
10,100
-4,000
-28% -$296K ﹤0.01% 1503
2021
Q1 		$1.08M Buy
14,100
+4,100
+41% +$373K ﹤0.01% 1345
2020
Q4 		$883K Sell
10,000
-1,300
-12% -$91.4K ﹤0.01% 1360
2020
Q3 		$834K Hold
11,300
– – ﹤0.01% 1333
2020
Q2 		$825K Buy
11,300
+3,600
+47% +$219K ﹤0.01% 1280
2020
Q1 		$432K Buy
+7,700
New +$337K ﹤0.01% 1381

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State of Wisconsin Investment Board's IGMS Position: Q1 2024 in Review

State of Wisconsin Investment Board sold out of IGM Biosciences (IGMS) in Q1 2024, closing a stake of 29,600 shares — an estimated $246K sold.

State of Wisconsin Investment Board first reported a position in IGMS in Q1 2020 and held it in 12 quarters. The position peaked at $1.17M in Q1 2022. 87 funds tracked by Wall St. Rank hold IGMS as of Q1 2024.

  • State of Wisconsin Investment Board reported no remaining IGM Biosciences position as of Q1 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 29,600 IGM Biosciences shares in Q1 2024, an estimated $246K.
  • State of Wisconsin Investment Board first reported a position in IGM Biosciences in Q1 2020 and held it in 12 quarters.
  • State of Wisconsin Investment Board's IGM Biosciences position peaked at $1.17M in Q1 2022.
  • 87 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2024, filed 14 May 2024.